Stereotaxis, Inc. STXS
1.03 USD -0.11 (-9.65%)
At closeNov 11, 2026, 5:04 AM EST
0.84 -0.19 -18.15%
Pre-market · Nov 11, 5:04 AM ET
1.03 Day range 1.14
0.80 52-week range 2.89
- YTD
- -55.22%
- 1 year
- -63.86%
News
marketbeat.com What Stereotaxis (STXS) Said on Its Q3 Earnings Call Stereotaxis NYSEAMERICAN: STXS reported a 20% increase in third-quarter revenue as early sales of its GenesisX robotic system and Synchrony operating room technology helped offset continuing catheter…
seekingalpha.com Stereotaxis, Inc. (STXS) Q3 2026 Earnings Call Transcript Stereotaxis, Inc. ( STXS ) Q3 2026 Earnings Call November 10, 2026 4:30 PM EST Company Participants David Fischel - CEO & Chairman Kimberly Peery - Chief Financial Officer Conference Call…
benzinga.com Stereotaxis Q3 2026 Earnings Call Transcript Stereotaxis (AMEX:STXS) reported third-quarter financial results on Tuesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by…
benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session Gainers Basel Medical Group (NASDAQ:BMGL) stock moved upwards by 13.9% to $2.2 during Tuesday's after-market session. The company's market cap stands at $73.3 million. Longeveron (NASDAQ:LGVN) stock…
benzinga.com Stereotaxis Announces Up To $24M Convertible Note Financing; $12M Initial Funding Plus $12M Milestone-Based Availability Stereotaxis, Inc. (NYSE:STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced it has entered into definitive agreements with…
benzinga.com Stereotaxis Q3 EPS $(0.07) Misses $(0.05) Estimate, Sales $8.925M Miss $9.600M Estimate Stereotaxis (AMEX:STXS) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $(0.05) by 40 percent. This is unchanged from the same period last year. The…
globenewswire.com Stereotaxis Reports 2026 Third Quarter Financial Results & Business Updates ST. LOUIS, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported business…
globenewswire.com Stereotaxis Announces Convertible Note Financing of Up To $24 Million ST. LOUIS, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced it has…
benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session Gainers Curis (NASDAQ:CRIS) stock moved upwards by 83.5% to $1.31 during Wednesday's pre-market session. The company's market cap stands at $1.7 million. SCWorx (NASDAQ:WORX) stock increased by…
benzinga.com Stereotaxis Announces 100% Clinical Success Rate For Its Robocath's Robotic System At Transcatheter Cardiovascular Therapeutics Conference; Technical Success Reported At 95% Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced the findings from the first-in-human clinical results for…- benzinga.com Canon Medical Systems, Stereotaxis Announce Technology Compatibility And Commercial Collaboration To Pair Alphenix Interventional Imaging Platform With Genesisx Robotic Magnetic Navigation System Collaboration brings together Canon’s Alphenix interventional fluoroscopy system and Stereotaxis’ GenesisX robotic technologyTechnologies will be presented at TCT 2026 in the Canon boothTUSTIN,…
benzinga.com Stereotaxis Says Pauls Stradiņš Clinical University Hospital In Latvia, Establishes Robotic Center For Treatment Of Cardiac Arrhythmias In Latvia And Treats Initial Patients With Genesis Robotic Magnetic Navigation System Pauls Stradiņš Clinical University Hospital installs Genesis Robotic Magnetic Navigation System, establishing the first robotic program for the treatment of cardiac arrhythmia in LatviaFirst…